Synexa Insights
The Latest Insights From Our Scientists
The STING Effect: How Biomarkers Expose Harmful Immune Responses
In this latest blog, we explore this pathway, its burgeoning links to multiple diseases and how biomarker profiling can assist in the development of targeted…
Falling drug approval rates: What should we be doing differently?
Over the years, this failure rate of drug approvals has not seen significant improvement, which begs the question - why?…
Patient Derived Organoids: Shaping the Fight Against Paediatric Brain Cancer
We highlight some of the exciting translational tools that have been developed to understand brain cancer and how these are…
Advancements in Antibody Therapies for Multiple Sclerosis
Multiple Sclerosis (MS) is a devastating autoimmune disease, characterised by neuronal inflammation which damages the myelin sheath, causing the demyelination…
Primary Immunodeficiency Week: The promise of gene therapy
In this blog, we delve deeper into the exciting world of gene therapy for PIDs.…
From Pottiphar to Potts: Skeletal TB from Ancient Egypt to the Present Day
Exploring the origins of TB in Ancient Egypt to present day biomarkers used to identify and treat the disease.…
Bridging the Gap: Translating Animal Model Findings to Clinical Oncology Breakthroughs
This blog delves into the historical significance, current challenges, and promising innovations shaping translational science research.…
Cardiovascular complications in chronic kidney disease: New biomarkers and treatment
Individuals with chronic kidney disease (CKD) are at a disproportionately high risk of cardiovascular events. Mechanistically, high salt and water…
Modelling Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): A rare autoimmune disease
On this rare disease day, we delve into Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP).…
World Cancer Day 2024: Closing the gap
February 4th 2024 marks World Cancer Day and the primary theme for this year is ‘closing the gap' in cancer…
Mycobacterium leprae: The lazy cousin to Tuberculosis
Leprosy, today known as Hansen's disease, is still prevalent in 2024. In this blog, we investigate look at the challenges,…
Improving the quality of human health
Contact us
Discuss biomarker and bioanalytical solutions to accelerate your therapeutic pipeline
